{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:18:40Z","timestamp":1776838720715,"version":"3.51.2"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73571-w","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T09:02:27Z","timestamp":1727946147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Leveraging programmed cell death signature to predict clinical outcome and immunotherapy benefits in postoperative bladder cancer"],"prefix":"10.1038","volume":"14","author":[{"given":"Yifan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"73571_CR1","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis, A. T., Lec, P. M., Chamie, K. & Mshs, M. D. Bladder Cancer: Rev. Jama 324, 1980\u20131991, doi:https:\/\/doi.org\/10.1001\/jama.2020.17598 (2020).","journal-title":"Bladder Cancer: Rev. Jama"},{"key":"73571_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"Cancer J. Clin."},{"key":"73571_CR3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo, N. et al. Epidemiology, screening, and Prevention of bladder Cancer. Eur. Urol. Oncol. 5, 628\u2013639. https:\/\/doi.org\/10.1016\/j.euo.2022.10.003 (2022).","journal-title":"Eur. Urol. Oncol."},{"key":"73571_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.biopha.2018.05.122","volume":"105","author":"Z Li","year":"2018","unstructured":"Li, Z. et al. Oncogene Mir-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer. Biomed. Pharmacotherapy = Biomedecine Pharmacotherapie.  105, 461\u2013469. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.122 (2018).","journal-title":"Biomed. Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"73571_CR5","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/s0140-6736(22)01188-6","volume":"400","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat, E. et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet (London England).  400, 1712\u20131721. https:\/\/doi.org\/10.1016\/s0140-6736(22)01188-6 (2022).","journal-title":"Lancet (London England)"},{"key":"73571_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.path.2019.11.002","volume":"13","author":"R Ruiz-Cordero","year":"2020","unstructured":"Ruiz-Cordero, R. & Devine, W. P. Targeted therapy and checkpoint immunotherapy in Lung Cancer. Surg. Pathol. Clin. 13, 17\u201333. https:\/\/doi.org\/10.1016\/j.path.2019.11.002 (2020).","journal-title":"Surg. Pathol. Clin."},{"key":"73571_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley, R. S., June, C. H., Langer, R. & Mitchell, M. J. Delivery technologies for cancer immunotherapy. Nat. Rev. Drug Discov. 18, 175\u2013196. https:\/\/doi.org\/10.1038\/s41573-018-0006-z (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"73571_CR8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1200\/jco.21.01845","volume":"40","author":"A Passaro","year":"2022","unstructured":"Passaro, A., Brahmer, J., Antonia, S., Mok, T. & Peters, S. Managing resistance to Immune checkpoint inhibitors in Lung Cancer: treatment and novel strategies. J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol. 40, 598\u2013610. https:\/\/doi.org\/10.1200\/jco.21.01845 (2022).","journal-title":"J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol."},{"key":"73571_CR9","doi-asserted-by":"publisher","first-page":"216807","DOI":"10.1016\/j.canlet.2024.216807","volume":"593","author":"H Lin","year":"2024","unstructured":"Lin, H. et al. LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer. Cancer Lett. 593, 216807. https:\/\/doi.org\/10.1016\/j.canlet.2024.216807 (2024).","journal-title":"Cancer Lett."},{"key":"73571_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/cdd.2015.126","volume":"23","author":"RA Lockshin","year":"2016","unstructured":"Lockshin, R. A. Programmed cell death 50 (and beyond). Cell Death Differ. 23, 10\u201317. https:\/\/doi.org\/10.1038\/cdd.2015.126 (2016).","journal-title":"Cell Death Differ."},{"key":"73571_CR11","doi-asserted-by":"publisher","first-page":"106936","DOI":"10.1016\/j.ijsu.2022.106936","volume":"107","author":"Y Zou","year":"2022","unstructured":"Zou, Y. et al. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int. J. Surg. (London England). 107, 106936. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106936 (2022).","journal-title":"Int. J. Surg. (London England)"},{"key":"73571_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.expneurol.2014.08.009","volume":"261","author":"GJ M\u00fcller","year":"2014","unstructured":"M\u00fcller, G. J., Hasseldam, H., Rasmussen, R. S. & Johansen, F. F. Dexamethasone enhances necrosis-like neuronal death in ischemic rat hippocampus involving \u00b5-calpain activation. Exp. Neurol. 261, 711\u2013719. https:\/\/doi.org\/10.1016\/j.expneurol.2014.08.009 (2014).","journal-title":"Exp. Neurol."},{"key":"73571_CR13","doi-asserted-by":"publisher","unstructured":"Liu, J. et al. Programmed cell death tunes Tumor Immunity. Front. Immunol. 13https:\/\/doi.org\/10.3389\/fimmu.2022.847345 (2022).","DOI":"10.3389\/fimmu.2022.847345"},{"key":"73571_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41420-021-00557-2","volume":"7","author":"W Lin","year":"2021","unstructured":"Lin, W., Chen, Y., Wu, B., Chen, Y. & Li, Z. Identification of the pyroptosis\u2013related prognostic gene signature and the associated regulation axis in lung adenocarcinoma. Cell. Death Discovery. 7, 161. https:\/\/doi.org\/10.1038\/s41420-021-00557-2 (2021).","journal-title":"Cell. Death Discovery"},{"key":"73571_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao, L. et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun. (London England).  42, 88\u2013116. https:\/\/doi.org\/10.1002\/cac2.12250 (2022).","journal-title":"Cancer Commun. (London England)"},{"key":"73571_CR16","doi-asserted-by":"publisher","first-page":"e108863","DOI":"10.15252\/embj.2021108863","volume":"40","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky, D. J. et al. Autophagy in major human diseases. EMBO J. 40, e108863. https:\/\/doi.org\/10.15252\/embj.2021108863 (2021).","journal-title":"EMBO J."},{"key":"73571_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei, M. L., Giannoni, E., Fiaschi, T. & Chiarugi, P. Anoikis: an emerging hallmark in health and diseases. J. Pathol. 226, 380\u2013393. https:\/\/doi.org\/10.1002\/path.3000 (2012).","journal-title":"J. Pathol."},{"key":"73571_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-023-03668-2","author":"C Li","year":"2023","unstructured":"Li, C. et al. Cuproptosis regulates Microenvironment and affects prognosis in prostate Cancer. Biol. Trace Elem. Res.https:\/\/doi.org\/10.1007\/s12011-023-03668-2 (2023).","journal-title":"Biol. Trace Elem. Res."},{"key":"73571_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan, J. & Ofengeim, D. A guide to cell death pathways. Nat. Rev. Mol. Cell Biol. 25, 379\u2013395. https:\/\/doi.org\/10.1038\/s41580-023-00689-6 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"73571_CR20","doi-asserted-by":"crossref","unstructured":"Xu, B. et al. Pan-cancer analysis reveals disulfidoptosis-associated genes as promising immunotherapeutic targets: insights gained from Bulk Omics and single-cell sequencing validation. Biomedicines.12, 267,  (2024).","DOI":"10.3390\/biomedicines12020267"},{"key":"73571_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P. & Kroemer, G. The molecular machinery of regulated cell death. Cell. Res. 29, 347\u2013364. https:\/\/doi.org\/10.1038\/s41422-019-0164-5 (2019).","journal-title":"Cell. Res."},{"key":"73571_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the nomenclature Committee on Cell Death 2018. Cell. Death Differ. 25, 486\u2013541. https:\/\/doi.org\/10.1038\/s41418-017-0012-4 (2018).","journal-title":"Cell. Death Differ."},{"key":"73571_CR23","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat. Commun. 13, 816. https:\/\/doi.org\/10.1038\/s41467-022-28421-6 (2022).","journal-title":"Nat. Commun."},{"key":"73571_CR24","doi-asserted-by":"publisher","first-page":"103750","DOI":"10.1016\/j.ebiom.2021.103750","volume":"75","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II\/III colorectal cancer. EBioMedicine. 75, 103750. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103750 (2022).","journal-title":"EBioMedicine"},{"key":"73571_CR25","doi-asserted-by":"publisher","unstructured":"Zhang, H. et al. Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma. Brief. Bioinform. 23https:\/\/doi.org\/10.1093\/bib\/bbac386 (2022).","DOI":"10.1093\/bib\/bbac386"},{"key":"73571_CR26","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48, W509\u2013w514. https:\/\/doi.org\/10.1093\/nar\/gkaa407 (2020).","journal-title":"Nucleic Acids Res."},{"key":"73571_CR27","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612. https:\/\/doi.org\/10.1038\/ncomms3612 (2013).","journal-title":"Nat. Commun."},{"key":"73571_CR28","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013d592. https:\/\/doi.org\/10.1093\/nar\/gkac963 (2023).","journal-title":"Nucleic Acids Res."},{"key":"73571_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"73571_CR30","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Science: Publication Protein Soc. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Science: Publication Protein Soc."},{"key":"73571_CR31","doi-asserted-by":"publisher","unstructured":"Song, D. & Wang, X. DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls. J. Translational Med. 20https:\/\/doi.org\/10.1186\/s12967-022-03355-1 (2022).","DOI":"10.1186\/s12967-022-03355-1"},{"key":"73571_CR32","doi-asserted-by":"publisher","unstructured":"Fu, J. et al. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 12https:\/\/doi.org\/10.1186\/s13073-020-0721-z (2020).","DOI":"10.1186\/s13073-020-0721-z"},{"key":"73571_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell. Rep. 18, 248\u2013262. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019 (2017).","journal-title":"Cell. Rep."},{"key":"73571_CR34","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han, Y. et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 51, D1425\u2013d1431. https:\/\/doi.org\/10.1093\/nar\/gkac959 (2023).","journal-title":"Nucleic Acids Res."},{"key":"73571_CR35","doi-asserted-by":"publisher","unstructured":"Bao, J. H. et al. Deciphering a Novel necroptosis-related miRNA signature for Predicting the prognosis of Clear Cell Renal Carcinoma. Anal. Cell. Pathol. (Amsterdam). 2022 (2721005). https:\/\/doi.org\/10.1155\/2022\/2721005 (2022).","DOI":"10.1155\/2022\/2721005"},{"key":"73571_CR36","doi-asserted-by":"publisher","unstructured":"Fu, L. et al. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma. Front. Immunol. 13https:\/\/doi.org\/10.3389\/fimmu.2022.1021935 (2022).","DOI":"10.3389\/fimmu.2022.1021935"},{"key":"73571_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","volume":"16","author":"JS O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell, J. S., Teng, M. W. L. & Smyth, M. J. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol. 16, 151\u2013167. https:\/\/doi.org\/10.1038\/s41571-018-0142-8 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"73571_CR38","doi-asserted-by":"publisher","first-page":"698677","DOI":"10.3389\/fimmu.2021.698677","volume":"12","author":"A Lin","year":"2021","unstructured":"Lin, A. & Yan, W. H. HLA-G\/ILTs targeted Solid Cancer Immunotherapy: opportunities and challenges. Front. Immunol. 12, 698677. https:\/\/doi.org\/10.3389\/fimmu.2021.698677 (2021).","journal-title":"Front. Immunol."},{"key":"73571_CR39","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The Immune Landscape of Cancer. Immunity. 48, 812\u2013830e814. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023 (2018).","journal-title":"Immunity"},{"key":"73571_CR40","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1158\/1078-0432.Ccr-19-0558","volume":"25","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. Combination of TMB and CNA Stratifies Prognostic and predictive responses to Immunotherapy Across Metastatic Cancer. Clin. cancer Research: Official J. Am. Association Cancer Res. 25, 7413\u20137423. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-0558 (2019).","journal-title":"Clin. cancer Research: Official J. Am. Association Cancer Res."},{"key":"73571_CR41","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s00432-015-1942-1","volume":"141","author":"A Rogler","year":"2015","unstructured":"Rogler, A. et al. Functional analyses and prognostic significance of SFRP1 expression in bladder cancer. J. Cancer Res. Clin. Oncol. 141, 1779\u20131790. https:\/\/doi.org\/10.1007\/s00432-015-1942-1 (2015).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"73571_CR42","doi-asserted-by":"publisher","first-page":"e44951","DOI":"10.1371\/journal.pone.0044951","volume":"7","author":"M Brait","year":"2012","unstructured":"Brait, M. et al. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers. PloS One. 7, e44951. https:\/\/doi.org\/10.1371\/journal.pone.0044951 (2012).","journal-title":"PloS One"},{"key":"73571_CR43","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/cac2.12470","volume":"43","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. An HGF-dependent positive feedback loop between bladder cancer cells and fibroblasts mediates lymphangiogenesis and lymphatic metastasis. Cancer Commun. (London England). 43, 1289\u20131311. https:\/\/doi.org\/10.1002\/cac2.12470 (2023).","journal-title":"Cancer Commun. (London England)"},{"key":"73571_CR44","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.7150\/ijbs.87182","volume":"19","author":"J Lv","year":"2023","unstructured":"Lv, J. et al. Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3\/PD-L1 cascade. Int. J. Biol. Sci. 19, 3744\u20133761. https:\/\/doi.org\/10.7150\/ijbs.87182 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"73571_CR45","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3892\/ol.2019.10570","volume":"18","author":"G Pang","year":"2019","unstructured":"Pang, G., Xie, Q. & Yao, J. Mitofusin 2 inhibits bladder cancer cell proliferation and invasion via the Wnt\/\u03b2-catenin pathway. Oncol. Lett. 18, 2434\u20132442. https:\/\/doi.org\/10.3892\/ol.2019.10570 (2019).","journal-title":"Oncol. Lett."},{"key":"73571_CR46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ijc.34265","volume":"152","author":"B Kim","year":"2023","unstructured":"Kim, B. et al. Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer. Int. J. Cancer. 152, 320\u2013330. https:\/\/doi.org\/10.1002\/ijc.34265 (2023).","journal-title":"Int. J. Cancer"},{"key":"73571_CR47","doi-asserted-by":"publisher","first-page":"108363","DOI":"10.1016\/j.abb.2020.108363","volume":"687","author":"J Li","year":"2020","unstructured":"Li, J. et al. Activation of FOXO3 pathway is involved in polyphyllin I-induced apoptosis and cell cycle arrest in human bladder cancer cells. Arch. Biochem. Biophys. 687, 108363. https:\/\/doi.org\/10.1016\/j.abb.2020.108363 (2020).","journal-title":"Arch. Biochem. Biophys."},{"key":"73571_CR48","doi-asserted-by":"publisher","first-page":"104092","DOI":"10.1016\/j.ebiom.2022.104092","volume":"81","author":"SW Baek","year":"2022","unstructured":"Baek, S. W. et al. YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer. EBioMedicine. 81, 104092. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104092 (2022).","journal-title":"EBioMedicine"},{"key":"73571_CR49","doi-asserted-by":"publisher","unstructured":"Wigner, P., Gr\u0119bowski, R., Bijak, M., Saluk-Bijak, J. & Szemraj, J. The interplay between oxidative stress, inflammation and angiogenesis in bladder Cancer Development. Int. J. Mol. Sci. 22https:\/\/doi.org\/10.3390\/ijms22094483 (2021).","DOI":"10.3390\/ijms22094483"},{"key":"73571_CR50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","volume":"45","author":"F Massari","year":"2016","unstructured":"Massari, F. et al. Metabolic phenotype of bladder cancer. Cancer Treat. Rev. 45, 46\u201357. https:\/\/doi.org\/10.1016\/j.ctrv.2016.03.005 (2016).","journal-title":"Cancer Treat. Rev."},{"key":"73571_CR51","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1111\/cas.14878","volume":"112","author":"GB Schulz","year":"2021","unstructured":"Schulz, G. B. et al. Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer. Cancer Sci. 112, 1987\u20131996. https:\/\/doi.org\/10.1111\/cas.14878 (2021).","journal-title":"Cancer Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73571-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73571-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73571-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T09:05:42Z","timestamp":1727946342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73571-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73571"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73571-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22976"}}